Status:
RECRUITING
RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)
Lead Sponsor:
European Institute of Oncology
Conditions:
Breast Cancer
Occult Breast Carcinoma
Eligibility:
FEMALE
18-90 years
Brief Summary
This is a monocentric prospective observational study for patients with clinical undetectable breast lesions and indications to breast conserving surgery for histological characterization. The SCOUT®...
Detailed Description
It has been estimated that 31,8% of breast cancer patients undergo pre-operational lesion localization. Of them, 19% have been previously administered neoadjuvant chemotherapy (NACT). Based on retrosp...
Eligibility Criteria
Inclusion
- Diagnosis of nonpalpable breast or lymph nodes
- Patients referred to IEO for breast surgery
- Patients between 18 and 90 years old
- Female patients
- Conservative surgery
- Patients willing and able to follow the study procedures and available for follow-up over the entire duration of the study
Exclusion
- Patients known or suspected to be allergic to materials similar to those in the SAVI SCOUT components (nickel)
- Any condition that may expose the individual to a higher risk or preclude the study from achieving full compliance or completion.
Key Trial Info
Start Date :
February 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05963464
Start Date
February 1 2023
End Date
December 31 2024
Last Update
August 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
European Institute of Oncology
Milan, Italy